Citadel Advisors
STJ

Citadel Advisors’s St Jude Medical STJ Stock Holding History

Citadel Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,000
Closed -$561K – 8535
2016
Q4 		$561K Buy
7,000
+2,400
+52% +$190K ﹤0.01% 4719
2016
Q3 		$367K Sell
4,600
-5,100
-53% -$412K ﹤0.01% 5346
2016
Q2 		$757K Sell
9,700
-1,100
-10% -$78.4K ﹤0.01% 3934
2016
Q1 		$594K Sell
10,800
-6,100
-36% -$332K ﹤0.01% 4166
2015
Q4 		$1.04M Sell
16,900
-18,500
-52% -$1.17M ﹤0.01% 3509
2015
Q3 		$2.23M Buy
35,400
+10,100
+40% +$721K ﹤0.01% 2801
2015
Q2 		$1.85M Sell
25,300
-30,400
-55% -$2.2M ﹤0.01% 3155
2015
Q1 		$3.64M Buy
55,700
+400
+0.7% +$26.6K ﹤0.01% 2369
2014
Q4 		$3.6M Buy
55,300
+24,600
+80% +$1.58M ﹤0.01% 2287
2014
Q3 		$1.85M Sell
30,700
-30,900
-50% -$2.02M ﹤0.01% 2938
2014
Q2 		$4.27M Buy
61,600
+27,100
+79% +$1.76M ﹤0.01% 1975
2014
Q1 		$2.26M Sell
34,500
-14,700
-30% -$957K ﹤0.01% 2528
2013
Q4 		$3.05M Sell
49,200
-8,700
-15% -$504K ﹤0.01% 2127
2013
Q3 		$3.11M Buy
57,900
+6,000
+12% +$309K ﹤0.01% 2002
2013
Q2 		$2.37M Buy
+51,900
New +$2.25M ﹤0.01% 2335

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citadel Advisors's STJ Position: Q4 2016 in Review

Citadel Advisors sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 49,900 shares — an estimated $3.96M sold.

Citadel Advisors first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $65.1M in Q1 2014. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Citadel Advisors reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Citadel Advisors sold 49,900 St Jude Medical shares in Q4 2016, an estimated $3.96M.
  • Citadel Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • Citadel Advisors's St Jude Medical position peaked at $65.1M in Q1 2014.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.